ORMP insider receives 75,670 shares in stock awards
By AlphaYouPublished Form 4
Reznick Yehuda
Reporting filer
Reznick Yehuda reported 75,670 shares of Common Stock in ORAMED PHARMACEUTICALS INC. as grants or awards dated 2026-11-12. The Form 4 was disclosed on Nov 14, 2026. These were stock awards, not open-market purchases.
- Disclosed
- Nov 14, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Reznick Yehuda | 2026-11-12 | A | Grant or award | 72780 | Not stated (see footnotes) | 177,960 | 2 days | Filed terms
|
| Common Stock | Reznick Yehuda | 2026-11-12 | A | Grant or award | 2890 | Not stated (see footnotes) | 180,850 | 2 days | Filed terms
|
Common Stock
- Owner
- Reznick Yehuda
- Date
- 2026-11-12
- Code
- A
- Action
- Grant or award
- Quantity
- 72780
- Price
- Not stated (see footnotes)
- Following holdings
- 177,960
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-12
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 72780
- id: F1
- id: F1
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 177960
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Reznick Yehuda
- Date
- 2026-11-12
- Code
- A
- Action
- Grant or award
- Quantity
- 2890
- Price
- Not stated (see footnotes)
- Following holdings
- 180,850
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-12
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 2890
- id: F2
- id: F2
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 180850
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Reznick Yehuda: Director.
- F1: On November 12, 2026, the issuer granted to the reporting person a restricted stock award of 72,780 shares under the issuer's Amended and Restated 2019 Stock Incentive Plan, representing the reporting person's annual Board awards for fiscal years 2027 and 2028. Of these shares, 36,390 vest in twelve substantially equal quarterly installments beginning April 1, 2027, and 36,390 vest in twelve substantially equal quarterly installments beginning April 1, 2028, in each case subject to the reporting person's continued service. No annual Board award will be granted to the reporting person for fiscal year 2028.
- F2: On November 12, 2026, the issuer granted to the reporting person a restricted stock award of 2,890 shares under the issuer's Amended and Restated 2019 Stock Incentive Plan, representing the reporting person's fiscal year 2027 committee awards, which vest in four substantially equal quarterly installments beginning April 1, 2027, subject to the reporting person's continued service.
Original sources
Prepared automatically from public filing data. Report a correction.